Drug intelligence / Profile preview

Rhizopus arrhizus var. arrhizus

Development stage: Unknown

Overview

Rhizopus arrhizus var. arrhizus is a variety of the fungus *Rhizopus arrhizus*, which is a prevalent opportunist causing human infections, particularly mucormycosis. It is also widely applied in the food industry and biotechnology for fermenting traditional foods and producing organic acids and hydrolytic enzymes. Furthermore, it is classified as a non-standardized fungal allergenic extract, used for its physiological effects on the immune system.

Other names: R. oryzae

Beyond the preview

Go deeper on Rhizopus arrhizus var. arrhizus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhizopus arrhizus var. arrhizus.

Explore the full profile